“…A quick look at the literature shows several works on derivatives of BZM, BTA, and BOX, especially those substituted at the 2 position, which have shown important biological activity against different types of neoplasms, including breast cancer [ 36 , 37 , 38 , 39 , 40 ]. It has been pointed out that the mechanisms of action of these benzo [ d ] [1,3] azole are different, highlighting in an important way the signaling pathways modulated by ERs [ 41 , 42 , 43 , 44 ]. Thus, following our continuous interest in the synthesis of benzofused heterocyclic derivatives and the study of their potential biological activities, in this opportunity, we report here the synthesis and characterization of a series of benzo [ d ] [1,3] azoles substituted at position 2 with benzyl and allyl-sulfanyl groups ( BTA-1 , BZM-2 , BOX-3 , BTA-4 , BZM-5 and BOX-6 ) and their preliminary in vitro cytotoxic assays against different human cancer cell lines.…”